Recognition, Prevention, Surveillance, and Management of Surgical Site Infections: Introduction to the Problem and Symposium Overview

Abstract
Surgical site infections (SSIs) are the second most common types of nosocomial infection in the United States. Approximately 500,000 SSIs occur annually, accounting for 3.7 million excess hospital days and >$1.6 billion in extra hospital charges [1]. Gram-positive organisms, many of which are resistant to multiple antimicrobial agents, are isolated from 46% of patients with SSIs. The problem of antimicrobial resistance in gram-positive nosocomial pathogens has been of growing concern and will continue to pose great clinical and epidemiological challenges in the foreseeable future.